This report aims to provide updated estimates of the burden of infections with selected bacterium–antibiotic resistance combinations in the EU/EEA in 2016-2020 and assess how this burden has changed from previous estimates.
The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC). The quality-assured data produced can be used to inform treatment guidelines.
This report describes and summarises the national results of the external quality assessment (EQA) of laboratory performance for those laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2021.
The results presented in this report are based on antimicrobial resistance (AMR) data from invasive isolates reported to the European Antimicrobial Resistance Surveillance Network (EARS-Net) by 29 European Union (EU) and European Economic Area (EEA) countries in 2021 (data referring to 2020), and on trend analyses of data reported by the continuously participating countries for the period 2016 to 2020.